China’s woes hurt Tiger Global and other hedge funds... [more]Komfie Manalo, Opalesque Asia: The $3.5bn Tiger Global Long-Only Opportunities fund, which is managed by Chase Coleman, the most prominent of Julian Robertson’s so-called Tiger Cub hedge fund managers, suffered a 7.4% loss in August, following the Chinese stock market turmoil.
According to th
Hedge fund executive Stuart Bohart leaves Fortress... [more]Komfie Manalo, Opalesque Asia: Stuart Bohart, president of Liquid Markets and Senior Managing Director at Fortress Investment Group (FIG), has left the firm. His departure follows disappointing performance and investor withdrawals from the firm’s macro hedge fund unit, reported
Regulatory - PTAB misconduct rule won't deter hedge fund attacks... [more]From Law360.com: The latest rule package for America Invents Act reviews would arm the Patent Trial and Appeal Board with the ability to sanction attorneys for not doing an adequate prefiling investigation and for making representations to the board for an "improper purpose," a new tool that attorne
Legal - Hedge fund manager Patrick Degorce loses tax appeal... [more]From FT.com: A prominent hedge fund manager will have to repay about £8m in tax after failing to overturn a tribunal ruling that found he had attempted to shelter millions in an avoidance scheme. Patrick Degorce, chief investment officer at Theleme Partners is well known in the City for co-founding
People - Viking hedge fund CFO departs... [more]From Reuters.com: Viking Global Investors Chief Financial Officer Barrett Brown is leaving the hedge fund management company to spend more time with his family, a person briefed on the situation said on Wednesday.
A search for a replacement CFO is underway, said the source, who is unauthorized
Activist News - Biogen patent survives challenge by hedge fund manager Bass... [more]From Reuters.com: In another setback for prominent hedge fund manager Kyle Bass and his campaign to eliminate some drug patents, the U.S. Patent and Trademark Office on Wednesday declined to hold a trial on the validity of a patent on Biogen Inc's multiple sclerosis drug Tecfidera.
…And Finally - A very highly committed person... [more]From Newsoftheweird.com: A woman identified only as Zeng, age 39, was finally imprisoned in August in Urumqi, China -- 10 years after she was convicted of corruption. Availing herself of a traditional "probation" option in Chinese law for expectant mothers, Zeng had remained free by getting herself